ATE121197T1 - Immunometrisches verfahren zum nachweis von lipoprotein-teilchen, anti-lp(a) monoklonale antikörper und ihre anwendung zur diagnose von atherosklerose. - Google Patents

Immunometrisches verfahren zum nachweis von lipoprotein-teilchen, anti-lp(a) monoklonale antikörper und ihre anwendung zur diagnose von atherosklerose.

Info

Publication number
ATE121197T1
ATE121197T1 AT89400142T AT89400142T ATE121197T1 AT E121197 T1 ATE121197 T1 AT E121197T1 AT 89400142 T AT89400142 T AT 89400142T AT 89400142 T AT89400142 T AT 89400142T AT E121197 T1 ATE121197 T1 AT E121197T1
Authority
AT
Austria
Prior art keywords
apob
lipoprotein particles
atherosclerosis
diagnosis
lipoprotein
Prior art date
Application number
AT89400142T
Other languages
English (en)
Inventor
Jean-Charles Fruchart
Dac Ngoc Vu
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8802214A external-priority patent/FR2627589B1/fr
Application filed by Pasteur Institut filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE121197T1 publication Critical patent/ATE121197T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT89400142T 1988-01-19 1989-01-18 Immunometrisches verfahren zum nachweis von lipoprotein-teilchen, anti-lp(a) monoklonale antikörper und ihre anwendung zur diagnose von atherosklerose. ATE121197T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14559788A 1988-01-19 1988-01-19
FR8802214A FR2627589B1 (fr) 1988-02-24 1988-02-24 Procede immunoenzymometrique selectif pour le dosage de lipoproteines contenant de l'apob ou un fragment de celle-ci, anticorps monoclonaux anti-lp(a) et application au diagnostic de l'atherosclerose

Publications (1)

Publication Number Publication Date
ATE121197T1 true ATE121197T1 (de) 1995-04-15

Family

ID=26226514

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89400142T ATE121197T1 (de) 1988-01-19 1989-01-18 Immunometrisches verfahren zum nachweis von lipoprotein-teilchen, anti-lp(a) monoklonale antikörper und ihre anwendung zur diagnose von atherosklerose.

Country Status (5)

Country Link
EP (1) EP0327418B1 (de)
JP (1) JPH026755A (de)
AT (1) ATE121197T1 (de)
DE (1) DE68922126T2 (de)
ES (1) ES2073448T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196324A (en) * 1989-12-15 1993-03-23 Eli Lilly And Company Monoclonal antibodies reactive with a human atheroma associated antigen
US5783400A (en) * 1990-04-27 1998-07-21 Genzyme Corporation Method for the isolation of lipoprotein allowing for the subsequent quantification of its mass and cholesterol content
AU672028B2 (en) * 1992-08-14 1996-09-19 Shino-Test Corporation Peptides containing respective amino acid sequences selected from among those of lipoprotein(a) and apolipoprotein(a), antibodies respectively recognizing these amino acid sequences, and method of assaying with these antibodies
DE59409345D1 (de) * 1993-02-09 2000-06-21 Roche Diagnostics Gmbh Lipoprotein (a)-Peptide und deren Verwendung
ATE193021T1 (de) * 1993-02-09 2000-06-15 Roche Diagnostics Gmbh Lipoprotein (a)-peptide und deren verwendung
US6727102B1 (en) 1997-06-20 2004-04-27 Leuven Research & Development Vzw Assays, antibodies, and standards for detection of oxidized and MDA-modified low density lipoproteins
US6309888B1 (en) 1998-09-04 2001-10-30 Leuven Research & Development Vzw Detection and determination of the stages of coronary artery disease
US6620787B2 (en) 2001-04-30 2003-09-16 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons
DE10353175A1 (de) * 2003-11-14 2005-06-16 Müller-Hermelink, Hans Konrad, Prof. Dr. Humaner monoklonaler Antikörper mit fettsenkender Wirkung
JP5298299B2 (ja) * 2007-09-28 2013-09-25 公益財団法人ヒューマンサイエンス振興財団 新規抗体、遺伝子、単鎖可変領域フラグメント、発現用ベクター、検出用キット、及び検出方法
WO2025199298A1 (en) * 2024-03-21 2025-09-25 Eli Lilly And Company BIOMARKER ASSAY TO MEASURE LIPOPROTEIN(a)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56118671A (en) * 1980-02-22 1981-09-17 Amano Pharmaceut Co Ltd Measuring method of specific enzyme immunity of hybrid type protein

Also Published As

Publication number Publication date
DE68922126T2 (de) 1995-11-09
ES2073448T3 (es) 1995-08-16
DE68922126D1 (de) 1995-05-18
JPH026755A (ja) 1990-01-10
EP0327418B1 (de) 1995-04-12
EP0327418A1 (de) 1989-08-09

Similar Documents

Publication Publication Date Title
ATE278192T1 (de) Einfaches immunochemisches semiquantitatives bestimmungsverfahren und gerät
EP0351248A3 (en) Detection of an antibody and antigen in an immunoassay
ATE152524T1 (de) Antigene zusammensetzungen aus fragmenten von campylobacter pylori und verfahren zu ihrer herstellung und verwendung
FI860112A0 (fi) Menetelmä ja laite immunoanalyysejä varten
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
ATE118275T1 (de) Immunoassayverfahren zum nachweis von antigenen.
ATE208900T1 (de) Verringerung des hook-effekts in immuntests mit teilchenförmigem trägermaterial
ATE121197T1 (de) Immunometrisches verfahren zum nachweis von lipoprotein-teilchen, anti-lp(a) monoklonale antikörper und ihre anwendung zur diagnose von atherosklerose.
ATE184108T1 (de) Mca prüfung/kit zum nachweis von metallkationen
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
ATE225512T1 (de) Abtrennungsverfahren
ATE112392T1 (de) Agglutinationskomplex zum nachweis von blutgruppen.
ATE220098T1 (de) Eine petroleum immuntestmethode und ihre komponenten
DE3686717D1 (de) Immuntestverfahren.
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
ATE191565T1 (de) Verfahren zum nachweisen von antikörpern und antigenen
GR940300091T1 (en) Equipment and test for determining an antigen/antibody in a test sample.
ATE111226T1 (de) Verfahren zum nachweis von analyten.
ATE278193T1 (de) Verfahren zum testen eines asialoglycoproteinrezeptors und testreagenz dafür
DE68919521D1 (de) Immuntest zum Nachweis von alpha-Haloacetamiden.
EP0096520A3 (de) Antigennachweis:Rheumatoide Arthritis
ATE64466T1 (de) Immuntest.
DE59005565D1 (de) Verfahren zur immunologischen Bestimmung von Bakterien der Gattung Aeromonas und der Spezies Vibrio cholerae.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee